Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR
Conditions: Giant Cell Arteritis; Polymyalgia Rheumatica Interventions: Drug: Secukinumab Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
The Effect of a 2-week Preoperative Vegan Diet Versus Omnivorous Diet on the Protein Turnover in the Osteoarthritic Knee
Conditions: Osteo Arthritis Knee; Protein Synthesis Interventions: Dietary Supplement: Vegan diet; Dietary Supplement: Omnivorous diet Sponsors: Wageningen University; Gelderse Vallei Hospital; Rijnstate Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Post Hoc Analysis Showed CIMZIA Resulted in Meaningful Efficacy for RA Patients with High Levels of Rheumatoid Factor (RF)
ATLANTA, Nov. 11, 2023. CB, a global biopharmaceutical company, will present a post hoc analysis of the EXXELERATE trial examining the efficacy of CIMZIA (certolizumab pegol) and adalimumab in patients with rheumatoid arthritis (RA) with high... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 13, 2023 Category: Pharmaceuticals Source Type: clinical trials
Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective Study
Conditions: Osteoarthritis, Knee; Rheumatoid Arthritis, Knee; Spontaneous Osteonecrosis of Knee Interventions: Procedure: Prepectoral; Procedure: Subpectoral Sponsors: Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
Conditions: Rheumatoid Arthritis Interventions: Drug: Test Product; Drug: Reference product; Drug: Reference Medicinal Product Sponsors: Dr. Reddy ' s Laboratories Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Impact of Hyperuricemia on Psoriatic Arthritis
Conditions: Psoriatic Arthritis Sponsors: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Perioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty
Conditions: Chronic Pain; Knee Pain Chronic; Post Operative Pain Interventions: Drug: Vitamin C; Drug: Placebo Sponsors: Mount Sinai Hospital, Canada; Canadian Institutes of Health Research (CIHR); The Arthritis Society, Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis
Conditions: Osteonecrosis of the Femoral Head; Avascular Necrosis of the Femoral Head Interventions: Procedure: Core Decompression; Procedure: Core Decompression Procedure with Autologous Bone Marrow Aspirate Concentrate Sponsors: Johns Hopkins University; Stanford University; Sinai Hospital of Baltimore; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis
Conditions: Knee Osteoarthritis; Osteo Arthritis Knee Interventions: Device: Microfragmented Adipose Tissue derived using the Lipogems ® System; Drug: Saline Injection Sponsors: Lipogems International spa; Alira Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis
OSAKA Japan and CAMBRIDGE, Massachusetts, November 7, 2023 – Takeda (TSE:4502/NYSE:TAK) today announced that the company will present positive results from its randomized, double-blind, placebo-controlled, Phase 2b trial evaluating... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 7, 2023 Category: Pharmaceuticals Source Type: clinical trials
Phase 2 Nipocalimab Data Establish Proof of Mechanism in Adults Living with Moderate to Severe Rheumatoid Arthritis, Supporting its Progression into a Combination Study
SPRING HOUSE, Pa., Nov. 7, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson& Johnson today announced data from the Phase 2a IRIS-RA clinical study for the treatment of adults living with moderate to severe active... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 7, 2023 Category: Pharmaceuticals Source Type: clinical trials
MISHA ™ Post-Market Clinical Study
Conditions: Osteo Arthritis Knee Interventions: Device: MISHA Knee System Sponsors: Moximed Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Self-Management Supported Telerehabilitation in Children and Adolescents With Juvenile Idiopathic Arthritis
Conditions: Telerehabilitation; Juvenile Idiopathic Arthritis; Self-Management Interventions: Other: Self-Management Supported Telerehabilitation Sponsors: Pamukkale University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants
Conditions: Rheumatoid Arthritis Interventions: Drug: AZD6912; Drug: Placebo Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
the Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA
Conditions: Arthritis Knee; Pain; Arthroplasty Complications Interventions: Procedure: primary unilateral TKA; Drug: Bupivacain; Drug: ketorolac; Drug: epinephrine; Drug: Paracetamol; Drug: Ketorolac; Drug: Tramadol Sponsors: Damascus University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials
